Literature DB >> 23602311

Superficial myxofibrosarcoma: assessment of recurrence risk according to the surgical margin following resection. A series of 21 patients.

G Riouallon1, F Larousserie, E Pluot, P Anract.   

Abstract

INTRODUCTION: Superficial myxofibrosarcomas are malignant connective tissue tumors, whose very frequent recurrence influences the local and vital prognosis. Even when resection seems to be macroscopically complete it is very often microscopically contaminated. The aim of this study was to evaluate recurrence in relation to the surgical margins and to compare, when possible, tumor size, evaluated clinically and macroscopically by the pathologist.
MATERIALS AND METHODS: This was a single center study of 21 patients, mean age 67 years old, treated for superficial myxofibrosarcoma. The number, date and location of recurrence were collected for each patient. A clinical and pathological measurement was made of the longest axis of the tumor in each case of recurrence.
RESULTS: Fifty-seven percent of patients presented with recurrent tumors. The mean number of recurrences was 1.4 per patient (1-8). The surgical margins were wide in four cases, marginal in two cases and incomplete/intralesional in 15 other patients with a rate of recurrence of 25, 50 and 67% respectively. The size evaluated during the preoperative clinical examination (14 cases) was underestimated by a mean 2.4 cm compared to the macroscopic pathology assessment. The preoperative size on MRI (5 cases) was also underestimated by a mean 1.3 cm.
CONCLUSION: Superficial myxofibrosarcomas are tumors that are difficult to resect completely because they are infiltrative, a feature that is often underestimated before surgery. Surgical treatment of this entity requires a much larger surgical margin than that suggested by the preoperative clinical and MRI evaluations. In case of incomplete resection, revision scar surgery should systematically be performed. LEVEL OF EVIDENCE: Level IV. Retrospective study.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23602311     DOI: 10.1016/j.otsr.2012.11.020

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  10 in total

1.  High-grade myxofibrosarcoma of the abdominal wall.

Authors:  Richard Antbring; Sam G Parker; Jeffrey T Lordan; Alastair Cj Windsor
Journal:  BMJ Case Rep       Date:  2017-06-02

2.  An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI.

Authors:  Kazutaka Kikuta; Daisuke Kubota; Akihiko Yoshida; Hideo Morioka; Yoshiaki Toyama; Hirokazu Chuuman; Akira Kawai
Journal:  Skeletal Radiol       Date:  2014-08-30       Impact factor: 2.199

3.  Preoperatively determining the margins of subcutaneous malignant soft tissue tumours using contrast-enhanced ultrasonography.

Authors:  Sota Oguro; Kazutaka Kikuta; Aya Sasaki; Kiyoshi Okuma; Shunsuke Matsumoto; Hiroaki Sugiura; Hideo Morioka; Masaya Nakamura; Morio Matsumoto; Masahiro Jinzaki
Journal:  J Med Ultrason (2001)       Date:  2017-09-11       Impact factor: 1.314

4.  Novel bone grafting technique in stand-alone ALIF procedure combining allograft and autograft ('Northumbria Technique')-Fusion rate and functional outcomes in 100 consecutive patients.

Authors:  Ata George Kasis; Cyrus Jensen; Rahul Dharmadhikari; Benjamin Ross Emmerson; Matthew Mawdsley
Journal:  Eur Spine J       Date:  2021-02-15       Impact factor: 3.134

5.  Preoperative Factors Associated with Infiltrative Histologic Growth Patterns in Extremity Soft Tissue Sarcoma.

Authors:  Jong Woong Park; Han-Soo Kim; Cheol Lee; Hye Jin Yoo; Ji Yeon Yun; Ilkyu Han
Journal:  Sarcoma       Date:  2017-07-20

6.  Distant metastasis in patients with myxofibrosarcoma.

Authors:  Hiroyuki Tsuchie; Mitsunori Kaya; Hiroyuki Nagasawa; Makoto Emori; Yasutaka Murahashi; Emi Mizushima; Naohisa Miyakoshi; Toshihiko Yamashita; Yoichi Shimada
Journal:  Ups J Med Sci       Date:  2017-08-17       Impact factor: 2.384

7.  MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases.

Authors:  Shirong Ma; Linni Fan; Yixiong Liu; Yingmei Wang; Kangjie Yu; Lifeng Wang; Na Fang; Fang Liu; Shuangping Guo; Zhe Wang
Journal:  Diagn Pathol       Date:  2018-08-21       Impact factor: 2.644

8.  5-Aminolevulinic acid tumor paint and photodynamic therapy for myxofibrosarcoma: an in vitro study.

Authors:  Shachar Kenan; Haixiang Liang; Howard J Goodman; Andrew J Jacobs; Amanda Chan; Daniel A Grande; Adam S Levin
Journal:  J Orthop Surg Res       Date:  2020-03-05       Impact factor: 2.359

Review 9.  Proteomic research in sarcomas - current status and future opportunities.

Authors:  Jessica Burns; Christopher P Wilding; Robin L Jones; Paul H Huang
Journal:  Semin Cancer Biol       Date:  2019-11-10       Impact factor: 15.707

10.  Primary low grade myxofibrosarcoma of the liver with benign presentation but malignant outcome: a case report.

Authors:  Zigong Shao; Baoping Jiao; Juanhan Yu; Hao Liu
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.